Alzheimer’s drug Leqembi has full FDA approval
U.S. officials have granted full approval to a closely watched Alzheimer’s drug for patients with early stages of the disease. The Food and Drug Administration decision clears the way for Medicare and other insurers to begin paying for the drug called Leqembi.
Top Stories
Alzheimer’s drug Leqembi has full FDA approval
Pope Francis dies at 88: A look at the Holy Father’s life
What happens after a pope’s death? Conclave, funeral-- explained
